Ruifeng Yang

1.0k total citations
44 papers, 661 citations indexed

About

Ruifeng Yang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ruifeng Yang has authored 44 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 29 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Ruifeng Yang's work include Hepatitis C virus research (28 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (19 papers). Ruifeng Yang is often cited by papers focused on Hepatitis C virus research (28 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (19 papers). Ruifeng Yang collaborates with scholars based in China, United States and Taiwan. Ruifeng Yang's co-authors include Christopher Aiken, Lai Wei, Mingli Qi, Huiying Rao, Angela M. Gronenborn, Jin-Woo Ahn, Hui Ma, Jin Qian, Guobing Xu and Zhiyan Li and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Virology.

In The Last Decade

Ruifeng Yang

43 papers receiving 649 citations

Peers

Ruifeng Yang
Kathrin Hueging Germany
Ling‐Pai Ting Taiwan
Shirin Nkongolo Germany
Nadia Warner Australia
F. Driss France
Stefan Mehrle Germany
Wenwei Yin China
Sue Ma United States
Antonio Madejón Spain
Noha G. Bader El Din Egypt
Kathrin Hueging Germany
Ruifeng Yang
Citations per year, relative to Ruifeng Yang Ruifeng Yang (= 1×) peers Kathrin Hueging

Countries citing papers authored by Ruifeng Yang

Since Specialization
Citations

This map shows the geographic impact of Ruifeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Yang more than expected).

Fields of papers citing papers by Ruifeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruifeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Yang. The network helps show where Ruifeng Yang may publish in the future.

Co-authorship network of co-authors of Ruifeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruifeng Yang. A scholar is included among the top collaborators of Ruifeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifeng Yang. Ruifeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Feng, Ruifeng Yang, Dongbo Chen, et al.. (2021). Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China. Journal of Virus Eradication. 7(2). 100040–100040. 7 indexed citations
2.
Yang, Ruifeng, Dongbo Chen, Ran Fei, et al.. (2021). A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma. Frontiers in Oncology. 11. 646638–646638. 4 indexed citations
3.
Feng, Bo, Ruifeng Yang, Haiying Zhang, et al.. (2019). Correlation analysis of hepatitis C virus core antigen and low viral loads: Can core antigen replace nucleic acid test?. Clinical and Experimental Medicine. 20(1). 131–141. 7 indexed citations
4.
5.
6.
Ma, Hui, Ruifeng Yang, Xiaohe Li, Jin Qian, & Lai Wei. (2016). HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b. Chinese Medical Journal. 129(18). 2212–2219. 20 indexed citations
7.
Rao, Huiying, Lai Wei, Hong Li, et al.. (2015). Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a C hinese H an population. Journal of Gastroenterology and Hepatology. 30(6). 1049–1056. 5 indexed citations
8.
Shang, Jia, Xiaoyuan Xu, Xinyue Chen, et al.. (2015). Efficacy and related factors of pegylated interferon α-2a plus ribavirin therapy for chronic hepatitis C in non-responders. 8(3). 232–237. 1 indexed citations
9.
Yang, Ruifeng, et al.. (2015). The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen. Journal of Virological Methods. 228. 39–47. 31 indexed citations
10.
Zhang, Cuiping, Lijun Liu, Yunzhong Wang, et al.. (2015). Prevalence and characterization of hepatitis B and C virus infections in a needle-sharing population in Northern China. BMC Public Health. 15(1). 460–460. 9 indexed citations
11.
Feng, Bo, Ruifeng Yang, Haiying Zhang, et al.. (2015). Early predictive efficacy of core antigen on antiviral outcomes in genotype 1 hepatitis C virus infected patients. The Brazilian Journal of Infectious Diseases. 19(4). 390–398. 3 indexed citations
12.
Yan, Linlin, Henghui Zhang, Hui Ma, et al.. (2015). Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients. Scientific Reports. 5(1). 17950–17950. 16 indexed citations
13.
Feng, Bo, Ruifeng Yang, Qing Xie, et al.. (2014). Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection. BMC Gastroenterology. 14(1). 47–47. 8 indexed citations
14.
Yoo, Soo Jin, Nattiya Hirankarn, Ruifeng Yang, et al.. (2014). Evaluation of the Elecsys® Anti-HCV II assay for routine hepatitis C virus screening of different Asian Pacific populations and detection of early infection. Journal of Clinical Virology. 64. 20–27. 20 indexed citations
15.
Yang, Ruifeng, Zhi Lin, Xiaoyong Liu, & Ge Zhang. (2014). A Clinical Study of Patients with Coronary Heart Disease Complicated with Hypertriglyceridemic Waist Phenotype. Cell Biochemistry and Biophysics. 70(1). 289–293. 3 indexed citations
16.
Yang, Ruifeng, et al.. (2013). Performance evaluation and comparison of the newly developed Elecsys anti-HCV II assay with other widely used assays. Clinica Chimica Acta. 426. 95–101. 20 indexed citations
17.
Yang, Ruifeng, Jiong Shi, In‐Ja L. Byeon, et al.. (2012). Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects. Retrovirology. 9(1). 30–30. 50 indexed citations
18.
Zhao, Gongpu, Danxia Ke, Jin-Woo Ahn, et al.. (2011). Rhesus TRIM5α Disrupts the HIV-1 Capsid at the InterHexamer Interfaces. PLoS Pathogens. 7(3). e1002009–e1002009. 74 indexed citations
19.
20.
Xu, Guizhi, et al.. (2009). Somatosensory-evoked potentials and cortical activities evoked by magnetic stimulation on acupoint in human. PubMed. 2009. 3445–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin Hueging Breakdown of academic impact, for papers by Ling‐Pai Ting Breakdown of academic impact, for papers by Shirin Nkongolo Breakdown of academic impact, for papers by Nadia Warner Breakdown of academic impact, for papers by F. Driss Breakdown of academic impact, for papers by Stefan Mehrle Breakdown of academic impact, for papers by Wenwei Yin Breakdown of academic impact, for papers by Sue Ma Breakdown of academic impact, for papers by Antonio Madejón Breakdown of academic impact, for papers by Noha G. Bader El Din
Rankless by CCL
2026